Hims & Hers (HIMS.US) Launches Menopause and Perimenopause Treatment Services, Shares Surge Over 15% in One Day

Stock News
Oct 16, 2025

Hims & Hers Health (HIMS.US) has announced the introduction of affordable treatment options for individuals experiencing perimenopause and menopause. This launch expands the company's business into the realm of hormone replacement therapy. The stock briefly surged over 20% during trading and closed up 16.18% on Wednesday, although it dipped 1.93% in after-hours trading. Hims & Hers anticipates that this new specialized service will help its "Hers" division achieve its goal of over $1 billion in annual revenue next year. The company stated that patients can collaborate with healthcare providers on its platform to receive treatment plans for menopause and perimenopause (the phase before menstruation ceases), including prescriptions, patches, or creams. According to the company, these treatment plans may involve hormones such as estradiol and progesterone. Estradiol can alleviate symptoms like hot flashes and night sweats, while progesterone can help improve sleep quality and protect the uterine lining.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10